Home > Insider Trading > Filing (0001225208-11-006700)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
9892	Bard C R Inc	BCR	Surgical & Medical Instruments & Apparatus (3841)	221454160

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1204669	K Bronwen Kelly	C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974	Vp - Human Resources	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-02-17	2,219	$76.40	24,566	No	4	A	Direct
Common Stock	Acquisiton	2011-02-17	950	$53.48	25,516	No	4	A	Direct
Common Stock	Acquisiton	2011-02-18	26,200	$35.71	51,716	No	4	M	Direct
Common Stock	Disposition	2011-02-18	27,442	$98.67	24,274	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (Right to Buy)	Disposition	2011-02-18	26,200	$0.00	26,200	$35.71

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2013-07-09	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	553	Indirect	401(k) Plan

Footnotes

Restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program.
Represents the weighted average sales price for price increments ranging from $98.59 to $98.95. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Also granted in tandem with these options are Limited Stock Appreciation Rights which can only be exercised upon a "Change of Control" as defined in the Plan.
This option, previously reported as covering 13,100 shares at an exercise price of $71.42, was adjusted to reflect the 2-for-1 stock split on May 28, 2004.
Options vest in accordance with schedule upon achievement of certain performance criteria or fully vest in five years.